Nrx Pharmaceuticals Stock Forecast

Buy or Hold candidate since Apr 06, 2026 Gain 84.00%

The NRx Pharmaceuticals, Inc. stock price gained 2.22% on the last trading day (Friday, 5th Jun 2026), rising from $4.05 to $4.14. During the last trading day the stock fluctuated 8.67% from a day low at $3.94 to a day high of $4.28. The price has risen in 5 of the last 10 days and is up by 35.29% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 0 shares were bought and sold for approximately $0 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 107.38% during the next 3 months and, with a 90% probability hold a price between $7.05 and $9.82 at the end of this 3-month period.

NRXP Signals & Forecast

The NRx Pharmaceuticals, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.33. On a fall, the stock will find some support from the long-term average at approximately $3.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 2.22%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for NRx Pharmaceuticals, Inc. stock

NRx Pharmaceuticals, Inc. finds support from accumulated volume at $4.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.341 between high and low, or 8.67%. For the last week the stock has had daily average volatility of 12.59%

Our recommended stop-loss: $3.96 (-4.38%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (NRXP) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect NRx Pharmaceuticals, Inc. to open at $4.12, and during the day (based on 14 day Average True Range), to move between $3.95 and $4.33, which gives a possible trading interval of +/-$0.386 (+/-9.78%) up or down from last closing price. If NRx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 9.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.05 (2.17%) than the resistance at $4.28 (3.38%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NRx Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NRx Pharmaceuticals, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.376 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $4.12 ( 0.555%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk